Traders Sell St. Jude Medical Inc. (STJ) on Strength (STJ)
Traders sold shares of St. Jude Medical Inc. (NYSE:STJ) on strength during trading on Friday. $210.13 million flowed into the stock on the tick-up and $239.81 million flowed out of the stock on the tick-down, for a money net flow of $29.68 million out of the stock. Of all stocks tracked, St. Jude Medical had the 0th highest net out-flow for the day. St. Jude Medical traded up $0.19 for the day and closed at $78.01
Several equities research analysts have recently commented on the company. JPMorgan Chase & Co. restated a “hold” rating on shares of St. Jude Medical in a report on Sunday, July 17th. Canaccord Genuity restated a “hold” rating on shares of St. Jude Medical in a report on Saturday, April 30th. Wells Fargo & Co. restated a “hold” rating on shares of St. Jude Medical in a report on Saturday, April 30th. Credit Suisse Group AG downgraded St. Jude Medical from an “outperform” rating to a “neutral” rating and boosted their price objective for the company from $67.00 to $81.00 in a report on Tuesday, May 3rd. Finally, Wedbush downgraded St. Jude Medical from an “outperform” rating to a “neutral” rating and boosted their price objective for the company from $70.00 to $84.00 in a report on Friday, July 15th. Twenty-two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus target price of $75.93.
The stock has a market cap of $22.23 billion and a PE ratio of 33.92. The company’s 50-day moving average is $82.13 and its 200 day moving average is $69.87.
St. Jude Medical (NYSE:STJ) last issued its quarterly earnings data on Wednesday, July 20th. The medical technology company reported $1.06 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.06. The firm earned $1.56 billion during the quarter, compared to the consensus estimate of $1.55 billion. The business’s revenue was up 10.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.07 EPS. Equities research analysts anticipate that St. Jude Medical Inc. will post $4.06 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, September 30th will be issued a $0.31 dividend. This represents a $1.24 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend is Wednesday, September 28th.
An institutional investor recently raised its position in St. Jude Medical stock. Advisors Asset Management Inc. boosted its stake in St. Jude Medical Inc. (NYSE:STJ) by 32.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,002 shares of the medical technology company’s stock after buying an additional 4,916 shares during the period. Advisors Asset Management Inc.’s holdings in St. Jude Medical were worth $1,236,000 as of its most recent SEC filing.
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.